TABLE 2.

FIMO scan for occupancy of KSHV LBS1-like sites on the human genome by kLANA.

Cell line	Binding to TSS (%)	LBS1-like sites occupied by kLANA (%)	kLANA peaks containing LBS1-like sites (%)	kLANA peaks detectable after I-BET151 treatment (%)
BCBL-1	65.6	0.18	50	28.57
BJAB-rKSHV.219	50	0.15	59.7	17.7
BJAB-kLANA	45	2.1	7.3	43.8

The second column shows the percent of kLANA peaks present within ±3 kbp of the TSS. Third column shows percent of KSHV LBS1-like sites occupied by kLANA on the human genome. The fourth column shows percent of total kLANA peaks on the human genome containing KSHV LBS1-like sites. Finally, the fifth column shows percent of kLANA peaks detectable after I-BET treatment.